Relay Therapeutics, Inc. Common Stock (RLAY)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Relay Therapeutics, Inc. Common Stock (RLAY) is listed on Nasdaq, where it has traded since July 16, 2020.
- Listed On
- Nasdaq
- Listed Since
- July 16, 2020
- Employees
- 192
- Market Cap
- $4.3B
About Relay Therapeutics, Inc. Common Stock
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 247 institutions reported holding RLAY, with 246.4 million shares worth $4.6 billion in aggregate. The largest reported holder was SB Investment Advisers (UK), with 27.9 million shares worth $522.1 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| SB Investment Advisers (UK) | 27,904,963 | $522M | Unchanged |
| FMR | 20,110,113 | $376M | Added 444.19% |
| Casdin Capital | 16,035,240 | $300M | Added 11.21% |
| BlackRock | 15,288,202 | $286M | Added 17.83% |
| Perceptive Advisors | 14,106,187 | $264M | Added 44.66% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RLAY?
Relay Therapeutics, Inc. Common Stock (RLAY) is listed on Nasdaq, where it has traded since July 16, 2020.
Who are the largest institutional holders of RLAY?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RLAY were SB Investment Advisers (UK), FMR and Casdin Capital.
How many institutions own RLAY?
247 institutions reported a position in RLAY for the quarter ended June 30, 2026, worth $4.6 billion in total.
Did institutions buy or sell RLAY last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for RLAY.
Every reported institutional holder, plus insider and congressional trades in RLAY, on SentiSense.